Successful Medical Management of Life-threatening Hepatic Hemangioma in Neonates.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 31511312.
- Also identified by DOI 10.1542/peds.2019-1339.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hepatic hemangioma (HH) is a common asymptomatic, self-limiting benign vascular tumor of the liver in neonates. Although complicated HHs are rare, they have significant risks of morbidity and mortality, especially during the perinatal period. Because of the high risks of complications from surgical interventions, there is an unmet need for effective medical therapy. We report 2 neonates with life-threatening HH who were evaluated for a liver transplant before being treated successfully with combined medical therapy, which included sirolimus, corticosteroids, and propranolol.
Medical subject headings
- Hemangioma
- Liver Neoplasms
- Methylprednisolone
- Propranolol
- Sirolimus